Allergan Aesthetics
Ashutosh Kulkarni is an experienced professional in the field of clinical pharmacology and development, currently serving as Project Director II for Early Portfolio Strategy and Operations at Allergan Aesthetics, an AbbVie Company since May 2024. Prior to this role, Ashutosh worked as a self-employed clinical pharmacology and non-clinical development consultant from September 2023 to May 2024, and held the position of Vice President - Clinical Pharmacology at Ventyx Biosciences from January to August 2023. Ashutosh also served as Executive Director and Head of Clinical Pharmacology and DMPK at Stealth Biotech PBC from August 2021 to December 2022, and as Executive Director of Clinical Pharmacology at AbbVie following the acquisition of Allergan from May 2020 to July 2021. Ashutosh holds a PhD in Pharmaceutical Sciences from the University of Southern California and an Executive MBA in Healthcare and Digital Transformation from the University of California, Irvine - The Paul Merage School of Business.
This person is not in any teams
This person is not in any offices
Allergan Aesthetics
7 followers
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. At Allergan Aesthetics™ we believe in the remarkable impact confidence can have on the lives, businesses, and careers of those we serve through our history of a company built on patient-care, education and support of our customers, and our commitment to putting the patients we serve first. That’s why we dedicate ourselves, every day, united by a single purpose: empowering confidence. For our customers, their patients and one another. Review our LinkedIn community guidelines at https://news.abbvie.com/social-media/